Loading...
A modified human ELISPOT assay to detect specific responses to primary tumor cell targets
BACKGROUND: The desired outcome of cancer vaccination is to induce a potent T cell response which can specifically recognize and eliminate autologous tumor cells in vivo. Accordingly, immunological assays that demonstrate recognition of native tumor cells (tumor-specific) may be more clinically rele...
Na minha lista:
Main Authors: | , , , , , , , |
---|---|
Format: | Artigo |
Sprog: | Inglês |
Udgivet: |
BioMed Central
2004
|
Fag: | |
Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC415560/ https://ncbi.nlm.nih.gov/pubmed/15050026 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1479-5876-2-9 |
Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|